MedDataX Logo

Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain

NCT ID: NCT00718406

Last Updated: 2008-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim was to evaluate the relief of chest pain during the first 30 minutes among patients who received metoprolol alone as compared with metoprolol plus morphine

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acute coronary syndrome Chest pain Betablockers Morphine Prehospital phase

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

A=metoprolol

Group Type ACTIVE_COMPARATOR

Metoprolol

Intervention Type DRUG

B

B=metoprolol plus morphine

Group Type ACTIVE_COMPARATOR

metoprolol plus morphine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Metoprolol

Intervention Type DRUG

metoprolol plus morphine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute chest pain
* ECG-signs indicating myocardial ischemia

Exclusion Criteria

* Heart rate \< 60 beats/min
* Systolic blood pressure \< 110 mmHg
* High degree AV-block
* Signs of obstructive pulmonary disease
* Signs of pulmonary oedema
* Unwillingness
* Participation in other studies
* Long delay between arrival of ambulance and randomisation
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role collaborator

Sahlgrenska University Hospital

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Institution, Dept of Molecular and Clinical Medicine, Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S203-02

Identifier Type: -

Identifier Source: org_study_id